The Role of Somatostatin in the Hemodynamics of the Hepatic Circulation in Patients Undergoing Liver Resection
Status:
Unknown status
Trial end date:
2020-07-31
Target enrollment:
Participant gender:
Summary
The purpose of the present clinical trial is to study the effect of somatostatin in the
regulation of velocity and blood flow of the hepatic circulation in patients undergoing liver
resection. The patients will be randomized in two groups: the study group will receive
somatostatin and the control group will receive the placebo. In both groups, patients will
undergo hepatectomy and directly postoperatively they will receive either somatostatin or
placebo, depending on their randomization. The primary endpoint will be the increase or
decrease of the velocity and the flow of the hepatic circulation estimated by ultrasonography
compared to the same parameters when measured preoperatively.